Skip to main content
Lung Cancer
Capmatinib for Patients with NSCLC with MET Exon 14 Mutation
Read More
Lung Cancer
Anti-TIGIT Antibody Tiragolumab plus Atezolizumab in Patients with PD-L1–Selected NSCLC
Read More
Lung Cancer
Phase 3 EMPOWER-Lung 1 Study of Cemiplimab in Advanced PD-L1–Positive NSCLC
Read More
Lung Cancer
Updated Analysis of PFS Data from Cohort G of KEYNOTE-021 in Nonsquamous NSCLC
Read More
Lung Cancer
Durvalumab Demonstrates Sustained Overall Survival in Unresectable Stage III NSCLC
Read More
Lung Cancer
ADAURA Results: Osimertinib as Adjuvant Therapy for EGFR-Mutated NSCLC
Read More
Lung Cancer
Neoadjuvant Nivolumab plus Chemotherapy Achieves Promising Responses in Resectable NSCLC (CheckMate-816)
Read More
Lung Cancer
Adjuvant Gefitinib versus Vinorelbine plus Cisplatin in Patients with Completely Resected Stage II to IIIA EGFR-Mutant NSCLC (ADJUVANT)
Read More
Lung Cancer
Stereotactic Body Radiotherapy versus Delayed Surgery for Early-Stage NSCLC
Read More
Lung Cancer
3-Year Follow-Up Data for Nivolumab Combined with Ipilimumab in Treatment-Naïve NSCLC: CheckMate-227
Read More
Page 127 of 199
Results 1261 - 1270 of 1986